School of Medicine
Showing 11-20 of 22 Results
Ira D Glick
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests Schizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry
Current Research and Scholarly Interests Ethics in Psychiatry, Mood disorders, Psychosomatic Medicine
Cheryl Gore-Felton, Ph.D.
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) at the Stanford University Medical Center
Current Research and Scholarly Interests My clinical focus is the treatment of anxiety disorders, including post traumatic stress disorder. My research focuses on developing effective psychotherapy interventions to reduce chronic stress as well as enhance positive health behaviors to reduce morbidity and mortality among patients coping with chronic, medical illnesses which are often life threatening.
Heather Jo Gotham
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Dr. Heather J. Gotham is a Clinical Associate Professor in the Department of Psychiatry & Behavioral Sciences, and member of the Center for Behavioral Health Services and Implementation Research in the Division of Public Mental Health & Population Sciences.
She is the Director of the Network Coordinating Office of the Mental Health Technology Transfer Center (MHTTC) Network funded by SAMHSA. The MHTTC Network consists of 10 regional centers, a National American Indian & Alaska Native Center, and a National Hispanic & Latino Center. The overarching goal of this network is the implementation and sustainment of evidence-based mental health prevention, treatment, and recovery support practices across US states and territories. She is also a consultant on two National Institute on Drug Abuse (NIDA) funded projects studying the implementation of substance use disorder screening and treatment approaches in HIV care settings.
Dr. Gotham has served as principal investigator, co-investigator or evaluator on SAMHSA, NIH, HRSA, and CDC grants. Her research focuses on implementation science, including factors affecting implementation, training and education of health care providers, and longitudinal course of implementation. Topics include substance use and mental health treatments for adolescents and adults, co-occurring mental health and substance use disorders, and screening, brief intervention, and referral to treatment (SBIRT).
Dr. Gotham assisted in the development of the Dual Diagnosis Capability in Addiction Treatment (DDCAT) index with Mark McGovern, and led the development of the Dual Diagnosis Capability in Mental Health Treatment (DDCMHT) index. She co-authored practice guidelines for co-occurring disorders treatment in the State of Missouri, and led the evaluation for Missouri?s COSIG (Co-occurring State Infrastructure Grant) grant as well as another foundation-funded multi-site co-occurring disorders initiative. She has served on several national and state-level expert panels, and provided training and technical assistance on co-occurring disorders at the national, state, and local levels.
Paired with her work in assisting providers to implement clinical protocols, Dr. Gotham has significant experience in clinical teaching and training behavioral health and health care students and professionals. This work includes serving as the supervisor of a clinical research rotation in an APA-approved psychology internship, and designing curricula and providing training and technical assistance to behavioral health and health professionals on treatments for adult and adolescent substance use disorders (including opioid use disorder), implementing EBPs into behavioral health settings, co-occurring mental health and substance use disorders and treatment, integrating behavioral and primary health, and SBIRT. Dr. Gotham led two SAMHSA-funded SBIRT health professions training grants, developing didactic, role play, standardized patient scenarios, and training vignettes for SBIRT, and teaching medical students and residents; baccalaureate and advanced practice nursing, dental, dental hygiene, master?s level social work, and clinical psychology PhD students; medical, dental, nursing, and behavioral health faculty; clinical preceptors; and community healthcare providers. She also has experience developing interactive online training.
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Born and raised in Caracas, Venezuela. Medical school at the Central University School of Medicine, where Internship was completed.
Residency training at Stanford Medical School, Department of Psychiatry. Work in Community Mental health in Maui, Hawaii for 4 years.
Work at the Veterans Administration in Palo Alto for 3 years. Currently in Private Practice and as consulting psychiatrist at the Vaden Student Health center at Stanford
Assistant Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Green is a physician-scientist and a child psychiatrist who work primarily with children with neurodevelopmental disorders such as ADHD and autism as well as with children with known genetic conditions (?neurogenetic syndromes? such as Noonan syndrome and other Rasopathies, Turner syndrome, 22q11.2 deletion syndrome). She gained her training as a child psychiatrist at Tel Aviv University in Israel. She has completed a postdoctoral research fellow in neuroscience at the Center for Interdisciplinary Brain Sciences Research at the Department of Psychiatry and Behavioral Sciences at Stanford University and currently, she is an Assistant Professor at the department. Dr. Green's research focus is the Rasopathies, a collection of syndromes associated with genetic mutations affecting the Ras/MAPK pathway. Among the Rasopathies, she is specifically interested in Noonan syndrome. These studies are directed at uncovering neural correlates associated with deficits in attention, memory and social skills in this syndrome. Results for this ongoing research also have the potential to yield valuable new insights into the role of the Ras/MAPK pathway in brain development in general, and attention, memory, and social skills.